ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

O. Trédan; C. Ménétrier-Caux; I. Ray-Coquard; G. Garin; C. Cropet; E. Verronèse; T. Bachelot; P. Rebattu; P.E. Heudel; P. Cassier; S. Chabaud; T. Croughs; P. Dupont; A.C. Cadore; G. Clapisson; A. Delgado; C. Bardin-dit-Courageot; C. Rigal; A. N'Kodia; L. Gilles-Afchain; M. Morre; D. Pérol; J.Y. Blay; C. Caux

Annals of Oncology (2015) - Comments
pubmed: 25851629 doi: 10.1093/annonc/mdv173 issn: 1569-8041 issn: 0923-7534

O. Trédan, C. Ménétrier-Caux, I. Ray-Coquard, G. Garin, C. Cropet, E. Verronèse, T. Bachelot, P. Rebattu, P.E. Heudel, P. Cassier, S. Chabaud, T. Croughs, P. Dupont, A.C. Cadore, G. Clapisson, A. Delgado, C. Bardin-dit-Courageot, C. Rigal, A. N'Kodia, L. Gilles-Afchain